CIK: 0001560009
申报总市值
US$1.4亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | 股票-其他 | 45.49% | -8.49% | -22.47% | |
| 2 | LENZ | Lenz Therapeutics INC | 股票-其他 | 28.14% | -10.95% | — | |
| 3 | JBIO | Jade Biosciences INC | 股票-其他 | 15.59% | -0.43% | — | |
| 4 | CRSP | CRISPR Therapeutics AG | 股票-医疗保健 | 5.17% | -0.16% | — | |
| 5 | CTNM | Contineum Therapeutics Inc-a | 股票-其他 | 4.11% | +0.90% | — | |
| 6 | SKYE | Skye Bioscience INC | 股票-其他 | 1.00% | -0.13% | — | |
| 7 | OVASUSD | Tempest Therapeutics INC | 股票-其他 | 0.51% | -0.20% | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | +25.8% | -22.47% | 减仓 |
| 2 | JBIO | Jade Biosciences INC | +9.4% | — | 不变 |
| 3 | CTNM | Contineum Therapeutics Inc-a | +1.1% | — | 不变 |
| 4 | CRSP | CRISPR Therapeutics AG | +0.6% | — | 不变 |
| 5 | OVASUSD | Tempest Therapeutics INC | -0.8% | — | 不变 |
| 6 | SKYE | Skye Bioscience INC | -2.7% | — | 不变 |
| 7 | LENZ | Lenz Therapeutics INC | -30.1% | — | 不变 |
| 8 | RPTX | Repare Therapeutics INC | — | EXIT | 清仓 |
| 9 | ADVMCHF | Adverum Biotechnologies INC | — | EXIT | 清仓 |